A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: Associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology

International Journal of Cancer

Volumn 134, Issue 12, 2014, Pages 2942-2950

  Song, Huan ^a   Michel, Angelika ^b   Nyrén, Olof ^a   Ekström, Anna Mia ^a   Pawlita, Michael ^b   Ye, Weimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

epidemiology; gastric cancer; Helicobacter pylori; virulence factors

Indexed keywords

BACTERIUM ANTIBODY; CAGA ANTIBODY; CAGA PROTEIN; CATALASE ANTIBODY; NAPA ANTIBODY; OMP ANTIBODY; UNCLASSIFIED DRUG; VACA ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NON CARDIA GASTRIC ADENOCARCINOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; STOMACH ADENOCARCINOMA; SWEDISH;

EPIDEMIOLOGY; GASTRIC CANCER; HELICOBACTER PYLORI; VIRULENCE FACTORS;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; CATALASE; CHAPERONIN 60; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; STOMACH NEOPLASMS; SWEDEN;

EID: 84897977055     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28621     Document Type: Article

References (28)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Gonzalez CA, Megraud F, Buissonniere A, et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol 2012; 23: 1320-4.
3. Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011; 16: 415-9.
4. Persson C, Jia YB, Pettersson H, et al. H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? Plos One 2011; 6: e17404.
5. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-7.
6. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104: 488-92.
7. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
8. Mazzoleni LE, Francesconi CF, Sander GB,. Mass eradication of Helicobacter pylori: feasible and advisable? Lancet 2011; 378: 462-4.
9. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004; 96: 388-96.
10. Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
11. Michel A, Waterboer T, Kist M, et al. Helicobacter pylori multiplex serology. Helicobacter 2009; 14: 525-35.
12. Gao L, Michel A, Weck MN, et al. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009; 69: 6164-70.
13. Epplein M, Zheng W, Xiang YB, et al. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidem Biomar 2012; 21: 2185-92.
14. Ekstrom AM, Held M, Hansson L, et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-91.
15. Annibale B, Lahner E, Santucci A, et al. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter 2007; 12: 23-30.
16. Ye W, Ekstrom AM, Hansson LE, et al. Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer 1999; 83: 223-9.
17. Lauren P,. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
18. Ekstrom AM, Signorello LB, Hansson LE, et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999; 91: 786-90.
19. Gao L, Weck MN, Michel A, et al. Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res 2009; 69: 2973-80.
20. Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008; 43: 1448-55.
21. He C, Chen M, Liu J, et al. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res 2013 Sep 25. [Epub ahead of print]
22. Posselt G, Backert S, Wessler S,. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal 2013; 11: 77.
23. Yu JLW, Go MY, Chan MC, et al. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002; 51: 480-4.
24. Weck MN, Gao L, Brenner H,. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology 2009; 20: 569-74.
25. de Sablet T, Piazuelo MB, Shaffer CL, et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011; 60: 1189-95.
26. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
27. Annibale B, Negrini R, Caruana P, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 2001; 6: 225-33.
28. Dinis-Ribeiro M, Yamaki G, Miki K, et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screening 2004; 11: 141-7.